Caris Life Sciences (CAI) vs Molina Healthcare (MOH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Molina Healthcare (MOH) has outperformed Caris Life Sciences (CAI) over the past year, losing 4.2% versus a loss of 14.2%. Molina Healthcare is the larger company by market cap ($10.17 billion vs $7.66 billion), about 1.3 times the size, while Caris Life Sciences is growing revenue faster (+97.0% vs +11.7%). On valuation, Molina Healthcare trades at a lower forward P/E (20.0x vs 73.6x for Caris Life Sciences).
Molina Healthcare converts more of its revenue into profit, with a net margin of 1.0% versus -8.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAI | MOH |
|---|---|---|
| Share price | $27.10 | $194.82 |
| Market cap | $7.66B | $10.17B |
| 1-day change | -1.29% | -0.18% |
| YTD return | +0.44% | +12.26% |
| 1-year return | -14.19% | -4.15% |
| 5-year return | — | -30.44% |
| P/E ratio (TTM) | 16.04 | — |
| Forward P/E | 73.60 | 19.99 |
| EPS (TTM) | $1.69 | $0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $812.03M | $45.43B |
| Revenue growth (YoY) | +96.97% | +11.75% |
| Net income (latest FY) | $-68.09M | $472.00M |
| Gross margin | — | 13.07% |
| Operating margin | 5.56% | 1.72% |
| Net margin | -8.38% | 1.04% |
| 52-week high | $33.65 | $244.89 |
| 52-week low | $14.19 | $121.06 |
| Distance from 52-week high | -19.47% | -20.45% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +7.31% | +7.34% |
| Average volume | 4.93M | 912.95K |
| Shares outstanding | 282.68M | 52.20M |
| Employees | 1,846 | 19,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MOH has outperformed CAI by 10.0 percentage points over the past year.
- Molina Healthcare is more profitable, keeping 1.0 cents of every revenue dollar as net income versus -8.4 cents for Caris Life Sciences.
- Caris Life Sciences grew revenue faster in its latest fiscal year (+96.97% vs +11.75%).
About Caris Life Sciences
CAI stock →Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.
Health Care · Medical Specialities · 1,846 employees
About Molina Healthcare
MOH stock →Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.
Health Care · Medical Specialities · 19,000 employees
CAI vs MOH FAQ
Which is bigger, Caris Life Sciences or Molina Healthcare?
Molina Healthcare (MOH) is larger, with a market capitalization of $10.17B compared with $7.66B for Caris Life Sciences (CAI).
Which stock has performed better over the past year, CAI or MOH?
MOH returned -4.15% over the past 12 months, compared with -14.19% for CAI (price return, excluding dividends). Past performance does not predict future results.
Are Caris Life Sciences and Molina Healthcare in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.